903434
Pomalidomide-PEG6-butyl azide
≥95%
Manufacturer: Sigma Aldrich
Synonym(S): Crosslinker–E3 Ligase ligand conjugate, Pomalidomide-2-2-2-2-2-2-6-N3, 24-azido-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-3,6,9,12,15,18-hexaoxatetracosanamide, Protein degrader building block for PROTAC® research, Template for synthesis of targeted protein degrader
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 MG | 903434-50-MG | In Stock | ₹ 45,389.23 |
903434 - 50 MG
In Stock
Quantity
1
Base Price: ₹ 45,389.23
GST (18%): ₹ 8,170.061
Total Price: ₹ 53,559.291
ligand
pomalidomide
Assay
≥95%
form
powder or crystals
reaction suitability
reaction type: click chemistryreagent type: ligand-linker conjugate
functional group
azide
storage temp.
2-8°C
SMILES string
O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NC(COCCOCCOCCOCCOCCOCCCCCCN=[N+]=[N-])=O)=O)NC1=O
Related Products
Description
- Application: Protein degrader builiding block Pomalidomide-PEG6-butyl azide enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand, a linker with both hydrophobic and hydrophilic moieties, and a pendant azide for click chemistry with a target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant azide group, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.
- Other Notes: Technology Spotlight: Degrader Building Blocks for Targeted Protein DegradationPortal: Building PROTAC® Degraders for Targeted Protein DegradationTargeted Protein Degradation by Small MoleculesSmall-Molecule PROTACS: New Approaches to Protein DegradationTargeted Protein Degradation: from Chemical Biology to Drug DiscoveryImpact of linker length on the activity of PROTACs
- Legal Information: PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
ligand: pomalidomide
Assay: ≥95%
form: powder or crystals
reaction suitability: reaction type: click chemistryreagent type: ligand-linker conjugate
functional group: azide
storage temp.: 2-8°C
SMILES string: O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NC(COCCOCCOCCOCCOCCOCCCCCCN=[N+]=[N-])=O)=O)NC1=O
ligand:
pomalidomide
Assay:
≥95%
form:
powder or crystals
reaction suitability:
reaction type: click chemistryreagent type: ligand-linker conjugate
functional group:
azide
storage temp.:
2-8°C
SMILES string:
O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NC(COCCOCCOCCOCCOCCOCCCCCCN=[N+]=[N-])=O)=O)NC1=O
ligand: pomalidomide
Assay: ≥95%
form: powder or crystals
reaction suitability: reactivity: sulfuryl reactivereagent type: ligand-linker conjugate
functional group: alkyl halide
storage temp.: 2-8°C
SMILES string: ICCCCCCOCCOCCOCCOCCOCCOCC(NC1=CC=CC2=C1C(N(C3CCC(NC3=O)=O)C2=O)=O)=O
ligand:
pomalidomide
Assay:
≥95%
form:
powder or crystals
reaction suitability:
reactivity: sulfuryl reactivereagent type: ligand-linker conjugate
functional group:
alkyl halide
storage temp.:
2-8°C
SMILES string:
ICCCCCCOCCOCCOCCOCCOCCOCC(NC1=CC=CC2=C1C(N(C3CCC(NC3=O)=O)C2=O)=O)=O
ligand: __
Assay: ≥99.0% (AT)
form: crystals
reaction suitability: __
functional group: __
storage temp.: __
SMILES string: Cl.CCN(CC)CC
ligand:
__
Assay:
≥99.0% (AT)
form:
crystals
reaction suitability:
__
functional group:
__
storage temp.:
__
SMILES string:
Cl.CCN(CC)CC
ligand: __
Assay: 0.95—1.05 mol
form: liquid
reaction suitability: __
functional group: __
storage temp.: __
SMILES string: __
ligand:
__
Assay:
0.95—1.05 mol
form:
liquid
reaction suitability:
__
functional group:
__
storage temp.:
__
SMILES string:
__